CAR-T Therapies May Be Linked to Secondary Tumors

The European Medicines Agency recently examined secondary tumors that developed in 38 out of approximately 42,500 patients who were administered CAR-T cells.
Medscape Medical News

source https://www.medscape.com/viewarticle/car-t-therapies-may-be-linked-secondary-tumors-2024a1000c7j?src=rss